Discover
BHVN
Biohaven Ltd.
13.62
900 x 13.49
200 x 13.56
bid
ask
-
0.27
1.94%
550 @ 07:30 PM
13.62 +0.00 (0.00%)
| Ytd | 20.64% | |
| 1y | -12.24% |
13.46
day range
14.28
7.79
52 week range
18.11
| Open | 14.07 | Prev Close | 13.89 | Low | 13.46 | High | 14.28 | Mkt Cap | 2.06B |
| Vol | 6.43M | Avg Vol | 2.94M | EPS | -4.55 | P/E | N/A | Forward P/E | -7.27 |
| Beta | 3.17 | Short Ratio | 6.71 | Inst. Own | 96.66% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-09 | 50-d Avg | 14.46 | 200-d Avg | 11.86 | 1yr Est | 21.27 |
| Income Statement | |||
| Operating Expenses | 124.90M | ||
| Research and Development Expense | 100.81M | ||
| Selling, General and Administrative Expense | 24.09M | ||
| Operating Income | -124.90M | ||
| Income Tax Expense | 391.00K | ||
| Net Income | -137.31M | ||
| Net Income Common Stock | -137.31M | ||
| Net Income Common Stock (USD) | -137.31M | ||
| Consolidated Income | -137.31M | ||
| Earnings per Basic Share | -0.91 | ||
| Earnings per Basic Share (USD) | -0.91 | ||
| Earnings per Diluted Share | -0.91 | ||
| Earning Before Interest & Taxes (EBIT) | -136.92M | ||
| Earning Before Interest & Taxes (USD) | -136.92M | ||
| Weighted Average Shares | 150.64M | ||
| Weighted Average Shares Diluted | 150.64M | ||
| Balance Sheet | |||
| Cash and Equivalents | 238.03M | ||
| Cash and Equivalents (USD) | 238.03M | ||
| Investments | 29.83M | ||
| Investments Current | 29.83M | ||
| Current Assets | 296.56M | ||
| Property, Plant & Equipment Net | 15.09M | ||
| Total Assets | 370.74M | ||
| Total Debt | 292.37M | ||
| Current Liabilities | 62.66M | ||
| Debt Non-Current | 292.37M | ||
| Total Liabilities | 358.52M | ||
| Accumulated Retained Earnings (Deficit) | -2.35B | ||
| Accumulated Other Comprehensive Income | 5.38M | ||
| Shareholders Equity | 12.22M | ||
| Shareholders Equity (USD) | 12.22M | ||
| Assets Non-Current | 74.18M | ||
| Total Debt (USD) | 292.37M | ||
| Goodwill and Intangible Assets | 19.79M | ||
| Liabilities Non-Current | 295.86M | ||
| Trade and Non-Trade Payables | 12.11M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.26M | ||
| Net Cash Flow from Financing | 3.80M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -36.48M | ||
| Capital Expenditure | -454.00K | ||
| Issuance (Purchase) of Equity Shares | 3.80M | ||
| Net Cash Flow from Investing | 44.82M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 45.28M | ||
| Net Cash Flow from Operations | -85.10M | ||
| Effect of Exchange Rate Changes on Cash | 3.00K | ||
| Share Based Compensation | 19.16M | ||